Skip to main contentA logo with &quat;the muse&quat; in dark blue text.
Novartis

Associate Director, Early HEOR (4 Positions)-US/Switzerland

United States

Job Description

Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With a strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly.

Early HEOR Associate Directors will work in partnership with Global TAs, other MAP functions, Regions, and priority countries, as well as R&D (NIBR & GDD) to support development and implementation of impactful HEOR and access-relevant evidence generation strategies and tactics that enable better patient outcomes, increased access, enhanced value proposition, and that support new commercial models. They will help to ensure HTA and payer evidence requirements are built into TPPs, clinical development plans, integrated evidence plans, and integrated product strategies.

Want more jobs like this?

Get Business Operations jobs delivered to your inbox every week.

Select a location
By signing up, you agree to our Terms of Service & Privacy Policy.


Early HEOR Associate Directors will support development and delivery of all aspects of the HEOR strategy and execution for priority assets from (pre-) POC up to FDP. This role will specifically focus on early assets residing within Global TA teams, up until assets transition to International TA teams. With Global TAs, early HEOR Associate Directors will co-develop HEOR strategies and tactics with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g. Italy and/or Spain) needs and feasibility. They will work in close partnership, collaborate and influence strategic TAs cross-functional teams, GPTs, R&D teams in NIBR & GDD, Region and priority Country teams to maximize patient outcomes and access and healthcare system value for early IM assets

Your responsibilities include, but are not limited to:
• Support the delivery of winning HEOR strategy and tactics, with high quality and on-time availability, including outcomes research and other relevant access and healthcare systems evidence and HEOR deliverables (incl. Global Value Dossier, Cost-effectiveness Models, Budget Impact Models, evidence synthesis, PCO or PRO strategy, access-enabling studies, etc.)
• Ensure that payer and healthcare needs are reflected into pivotal clinical programs as well as phase 3b/4, RWE and integrated evidence plans to meet the needs of external experts and institutions involved in reimbursement, pricing, access and healthcare systems decisions.
• Help to oversee delivery of access-relevant evidence required by country teams in prioritized markets to achieve reimbursement and other positive funding recommendations and optimal access.
• Help to establish and maintain relationships with key economic modelling, outcomes research and HEOR talent and leaders in the field, both outside and inside the company; facilitate sharing of learnings and hands-on utilization of HEOR deliverables and evidence throughout the organization.
• Stay abreast of internal and external developments, trends and other dynamics that affect the HEOR and HTA domain and shares learnings with team and the broader organization.
• Support Head of Early HEOR, as well as Head of HEOR & PCO in external engagement (with HTA bodies, policy makers, regulatory agencies, HEOR scientific groups) to shape the HTA environment, the HEOR field and informs the organization on opportunities and risks.
• Build strong partnerships within Value & Access, Medical Affairs, Global TAs, regional and country counterparts. Collaborate with global regulatory, therapy area policy and access colleagues in seeking early scientific advice from payer, policy maker, and regulatory agencies in prioritized countries.
• Embrace change, help implement the new ways of working from Transforming for Growth, develop and improve improved ways of working with a focus on flexibility and efficiency.

The role can be based in either Switzerland and/or USA.
Our selection process will prioritize associates whose roles may be changing or may be impacted as a result of the Transforming for Growth reorganization.

For US based candidates:
The ideal location for this role is East Hanover, NJ but remote work may be possible (there may be some restrictions based on legal entity). Please note that this role would not provide relocation as a result. If associate is remote, all home office expenses and any travel/lodging to specific East Hanover, NJ for periodic live meetings will be at the employee's expense. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require 20% travel.

Diversity & Inclusion / EEO

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Minimum Requirements

What you'll bring to the role:
• 5+ years of experience at pharmaceutical or life-science consulting companies with at least 3 years in HEOR, RWE, market access or other relevant role
• Advanced Degree; preferably Ph.D., M.D., MBA, RPh or equivalent
• Subject matter expertise in HEOR, incl. deep understanding of HEOR and other approaches to generate payer and HCS evidence; preferably subject matter expertise in RWE, capability in designing winning access-relevant RWE studies, analyzing and publishing RWE data and using the results to make impact with access-relevant customers
• Customer-centric mindset, passion, strong knowledge and alignment to payer, patient, access, HCS customers mindset, evidence requirements and decision-making dynamics; deep understanding of payer/HTA evidence requirements and decision-making dynamic cross countries/regions (preferably: an active external network with HEOR, RWE and health policy OLs)
• Impact-oriented, enterprise and agile mindset with proven track record of fostering innovation, ability to work in agile manner, and strong process/project management skills
• Experience working in global or above-country multidisciplinary drug development and product teams. Preferred: A proven track record of influencing development plans or IEPs to meet the needs of payers or other HCS decision makers; influencing in matrix organization balancing cross-functional perspectives and alignment with business priorities
• Preferred: knowledge of research methodology and statistical methods in the field of data analysis, and considerable experience collaborating with quantitative scientists and analysts
• Preferred: Significant (3+ years) and recent (post 2015) US in-market experience: includes working in the US market with the local US customers, US health care systems / systems of care, US payors / accounts, US market strategy etc.

#transformingforgrowth

Why Novartis?
766 million lives were touched by Novartis medicines in 2021, and while we're proud of this, we know there is so much more we could do to help improve and extend people's lives.

We believe new insights, perspectives and ground-breaking solutions can be found at the intersection of medical science and digital innovation. That a diverse, equitable and inclusive environment inspires new ways of working.

We believe our potential can thrive and grow in an unbossed culture underpinned by integrity, curiosity and flexibility. And we can reinvent what's possible, when we collaborate with courage to aggressively and ambitiously tackle the world's toughest medical challenges. Because the greatest risk in life, is the risk of never trying!
Imagine what you could do here at Novartis!

Commitment to Diversity & Inclusion:

Novartis is committed to building an outstanding, inclusive work environment and diverse
teams representative of the patients and communities we serve.

Accessibility and Reasonable Accommodations: Individuals in need of a reasonable accommodation due to a medical condition or disability for any part of the application process, or to perform the essential functions of a position, please send an e-mail to [email protected] or call +1 (877)395-2339 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.

Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to hear more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network

Division
PHARMA

Business Unit
GLOBAL PRODUCT & PORTFOLIO STRATEGY

Location
Switzerland

Site
Basel

Company / Legal Entity
Novartis Pharma AG

Alternative Location 1
USA

Alternative Location 2
Ireland

Alternative Location 3
United Kingdom

Functional Area
Market Access

Job Type
Full Time

Employment Type
Regular

Shift Work
No

Client-provided location(s): United States; Basel, Switzerland; United Kingdom; Ireland
Job ID: Novartis-358031BR
Employment Type: Other

This job is no longer available.

Search all jobs